jeudi 15 mars 2018

Onco Actu du 15 mars 2018

3. Prévention

Drug Combination Reduces Number of Colorectal Polyps in Patients with Hereditary Cancer Syndrome [NCI]

3.2 Prévention - Obésité

Obesity risk doubles for teens bombarded with junk food adverts [Cancer Research UK]

4. Dépistage, diagnostic et pronostic

Scientists caution that a rare childhood liver cancer can spread to the brain [The Rockefeller University]

Doctors hunt for hidden cancers with glowing dyes [STAT]

4.2 Dép., diag. & prono. - Génome

Genetic Testing Co. Probe `Ominous’ for Diagnostics Scrutiny [Bloomberg]

5. Traitements

The power of precision medicine in cancer drug discovery and treatment [Institute of Cancer Research]

5.1 Traitements - Pré-clinique

Obesity may promote resistance to antiangiogenic therapy for breast cancer [Mass. General Hospital]

Researchers use novel methods to determine drug uptake for tumours [EPR]

“Body on a chip” could improve drug evaluation [MIT News]

5.12.6 Immunothérapies - AMM

FDA Grants Priority Review to Merck’s Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab) for Treatment of Advanced Cervical Cancer [Merck]

Speedy US review for MSD’s Keytruda in cervical cancer [PharmaTimes]

5.2 Pharma

Tracking a successful DLBCL assault in Phase II, MorphoSys sets out to seize quick OK for MOR208 [EndPoints]

5.4 Traitements - Economie

Oncologists’ Charge Amounts Are Higher Than Other Specialties’ [Health Affairs Blog]

5.9.8 AACR - Pharma

Halozyme To Present Data From Six Nonclinical Studies At American Association Of Cancer Research Annual Conference [Halozyme]

Research from Bristol-Myers Squibb’s Innovative Oncology Development Program to Be Presented at AACR 2018 Demonstrates Commitment to Advancing Precision Medicine Research for Patients with Cancer [BMS]

6. Lutte contre les cancers

Depression Treatment Does Not Improve the Survival of Depressed Patients with Cancer [ESMO]

6.1 Observation

Black Cancer Matters [NY Times]

Breast cancer patients in U.S. territories receive lower quality care [Reuters]

6.10 Politiques

The Guardian view on denying cancer care: unjust and uncaring [The Guardian]

6.6 Publications

Cancer biologist retracts five papers [Retraction Watch]

Meta-research: Why research on research matters [PLoS Biology]

6.9 Controverses

The SEC Says Elizabeth Holmes' Fraud Was Worse Than Anyone Thought [Forbes]

Theranos and Silicon Valley's 'Fake It Till You Make It' Culture [Wired]